首页> 外国专利> New attenuated myxoma recombinant virus and its use in the preparation of mixed vaccines against myxomatosis and rabbit hemorrhagic disease

New attenuated myxoma recombinant virus and its use in the preparation of mixed vaccines against myxomatosis and rabbit hemorrhagic disease

机译:新型减毒粘液瘤重组病毒及其在制备抗粘液瘤和兔出血性疾病混合疫苗中的应用

摘要

It is here described a new recombinant myxoma virus deposited in the CNCM with deposit number I-1990, that contains within its genome a nucleotide sequence capable of expressing the antigen protein VP60 of the rabbit hemorrhagic disease virus, which is attenuated and exhibits a controlled transmission capacity, as well as the combined anti-myxomatosis and anti-RHDV vaccines - self-propagating in a controlled manner - obtained from the aforesaid virus. Also described, is a method for obtaining attenuated recombinant myxoma virus useful in the preparation of self-propagating combined vaccines against myxomatosis and other infectious diseases of leporids. IMAGE
机译:这里描述了一种新的重组粘液瘤病毒,保藏在CNCM,保藏号为I-1990,其基因组中包含一个能够表达兔出血性疾病病毒抗原蛋白VP60的核苷酸序列,该核苷酸蛋白被减毒并显示出受控的传播从上述病毒获得的能力,以及以受控方式自我繁殖的抗粘瘤病和抗RHDV组合疫苗。还描述了一种获得减毒的重组粘液瘤病毒的方法,该病毒可用于制备抗粘液瘤病和脂蛋白体的其他传染性疾病的自繁殖组合疫苗。 <图像>

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号